Heart failure with preserved pumping function study in the UK
Part of Heart & circulation clinical trials.
This trial studies people who have heart failure symptoms but whose heart pumping strength is largely preserved. It aims to better understand this specific type of heart failure and how best to treat or evaluate it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a consent form and agree to take part
- A heart specialist (or trained primary care clinician/heart failure nurse) has diagnosed you with HFpEF
- You have had a blood test for natriuretic peptides (a heart stress marker)
- Your heart pumping strength (left ventricular ejection fraction) is not under 40%
- Your diagnosis does not have certain other heart causes (for example, amyloid or sarcoid) that would exclude you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the different features and patterns of people with heart failure where the heart’s pumping strength is preserved. It may help doctors better understand your type of heart failure and tailor care.
This study looks at whether fat around the heart affects a type of heart failure where the heart pumps well but is stiff (HFpEF). You may be able to join if you have this condition, are 18 or older, and can understand English.
This study helps doctors better understand a type of heart failure where the heart pumps normally but has trouble relaxing and filling with blood. Researchers will use ultrasound, blood tests, and clinical information to identify different subtypes and improve treatment.
This study looks for people who may have a type of heart failure where the heart pumps normally but still doesn't work well. It aims to better understand who gets this condition and how to spot it earlier.
This study is for people in the Capital Region of Denmark who are at least 50 years old and have certain health conditions that put them at risk for a type of heart failure where the heart pumps normally but doesn't relax properly. The study aims to find and help people before heart failure develops.
This study tests an investigational medication called elecoglipron to see if it can improve heart and blood vessel outcomes in people with heart failure with preserved or mildly reduced ejection fraction. If you join, you will receive either the study drug or a placebo, and your heart health will be monitored over time.
Hear when a new Heart Failure With Preserved Ejection Fraction (HFpEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.